Safety and Efficacy of Palliative Transurethral Resection of the Prostate

Strategic Insights -

A recent meta-analysis published in the World Journal of Urology has evaluated the safety and efficacy of palliative transurethral resection of the prostate (TURP) for relieving urinary obstruction in patients with metastatic prostate cancer. The study, conducted by researchers from the University of Florida, included eight studies with a total of 3,080 patients with advanced prostate cancer. The analysis found that palliative TURP significantly reduced postvoid residual urine volume by a mean difference of 50.41 milliliters, with a 95% confidence interval of 39.49-61.34.

Key Takeaways:

  • The meta-analysis included eight studies with a total of 3,080 patients with advanced prostate cancer, making it one of the largest studies on this topic.
  • Palliative TURP significantly reduced postvoid residual urine volume, with a mean difference of 50.41 milliliters, indicating significant improvement in urinary symptoms.
  • The study used a comprehensive literature search to identify studies published before August 2024, ensuring that the results were based on the most recent data available.
  • The researchers used the Newcastle Ottawa Scale to evaluate study quality and the Risk of Bias in Non-randomized Studies of Interventions tool to assess bias, indicating a high level of rigor in the analysis.
  • The study concluded that while palliative TURP offers symptomatic relief, the risk of postoperative complications should be carefully considered in treatment planning.
  • The researchers included data from the University of Florida Department of Urology, highlighting the importance of academic institutions in advancing research in this field.
  • The study's findings have implications for the management of urinary obstruction in patients with metastatic prostate cancer, a common complication of this disease.
  • The analysis used Comprehensive Meta-Analysis and Review Manager software to analyze the results, indicating a high level of statistical sophistication.

Statistics:

  • 3,080 patients with advanced prostate cancer were included in the study, making it one of the largest studies on this topic.
  • 50.41 milliliters is the mean difference in postvoid residual urine volume reduction after palliative TURP, with a 95% confidence interval of 39.49-61.34.
  • 8 studies were included in the meta-analysis, with a comprehensive literature search conducted to identify eligible studies.
  • 95% confidence interval (39.49-61.34) indicates a high level of precision in the results.
  • 50.41 milliliters is a significant reduction in postvoid residual urine volume, indicating a substantial improvement in urinary symptoms.

Sources:

  • NewsRx. Data from University of Florida Advance Knowledge in Prostate Cancer (Safety and Efficacy of Palliative Transurethral Resection of the Prostate for Lower Urinary Tract Obstruction In Patients With Metastatic Prostate Cancer: a Meta-analysis). Cancer Weekly. June 17, 2025; p 940.
  • World Journal of Urology. Safety and Efficacy of Palliative Transurethral Resection of the Prostate for Lower Urinary Tract Obstruction In Patients With Metastatic Prostate Cancer: a Meta-analysis. 2025;43(1).
  • Springer. World Journal of Urology. www.springerlink.com/content/0724-4983/
  • University of Florida Department of Urology. Jacksonville, FL 32610, United States.